A description of cellular involvement in the imipramine-serotonin experimental animal myopathy : a model disease for Duchenne muscular dystrophy /

A description of cellular involvement in the imipramine-serotonin experimental animal myopathy : a model disease for Duchenne muscular dystrophy /

Bibliographic Details
Main Author:	Silverman, Lawrence Mark
Language:	English
Published:	The Ohio State University / OhioLINK 1975
Subjects:	Chemistry Muscular dystrophy Imipramine Serotonin
Online Access:	http://rave.ohiolink.edu/etdc/view?acc_num=osu1486993219478475

Similar Items

Imipramine-serotonin induced membrane changes leading to enzyme release /
by: Verrill, Harland L.
Published: (1976)

Duchenne muscular dystrophy: an historical treatment review
by: Lineu Cesar Werneck, et al.

Duchenne and Becker muscular dystrophy: implications for at-risk individuals
by: Erasmus, Suretha
Published: (2010)

Glucocorticoids for Duchenne Muscular Dystrophy
by: J Gordon Millichap
Published: (2013-07-01)

Duchenne and Becker muscular dystrophy in adolescents: current perspectives
by: Andrews JG, et al.
Published: (2018-03-01)

Strengthen the research of Duchenne muscular dystrophy in China
by: Cheng ZHANG
Published: (2015-06-01)

Delay in Diagnosis of Duchenne Muscular Dystrophy
by: Vamshi K Rao, et al.
Published: (2015-01-01)

Molecular analysis of Duchenne muscular dystrophy
by: Smith, T. J.
Published: (1988)

Natural history of Duchenne muscular dystrophy
by: Qing KE, et al.
Published: (2015-05-01)

Rehabilitation therapy of Duchenne muscular dystrophy
by: Cheng ZHANG, et al.
Published: (2012-06-01)

Errata: Measuring Disease Severity in Duchenne and Becker Muscular Dystrophy
by: Melinda F. Davis, et al.
Published: (2011-05-01)

The golden retriever model of Duchenne muscular dystrophy
by: Joe N. Kornegay
Published: (2017-05-01)

Validation of Chemokine Biomarkers in Duchenne Muscular Dystrophy
by: Michael Ogundele, et al.
Published: (2021-08-01)

Muscular Fatigue in Duchenne Dystrophy
by: J Gordon Millichap
Published: (1995-02-01)

Mutation detection and the use of tissue expression profiling to elucidate the pathogenesis of Duchenne Muscular Dystrophy.
by: Hallwirth Pillay, Kumari Devi.
Published: (2014)

Pain characterization in Duchenne muscular dystrophy
by: Talita Dias da Silva, et al.

A Descriptive Study on the Effect of Carrier Status on Mothers’ Wellbeing and Adaptation to Duchenne and Becker Muscular Dystrophy
by: Khudai, Chandni
Published: (2012)

Nutraceuticals and Their Potential to Treat Duchenne Muscular Dystrophy: Separating the Credible from the Conjecture
by: Keryn G. Woodman, et al.
Published: (2016-11-01)

Early Development in Duchenne Muscular Dystrophy
by: J Gordon Millichap
Published: (1990-07-01)

The research status and problems of Duchenne muscular dystrophy in China
by: Cheng ZHANG, et al.
Published: (2018-07-01)

The evolution of electrocardiographic changes in patients with Duchenne muscular dystrophies
by: Woo Hyun Yoo, et al.
Published: (2017-06-01)

Comparative proteomic analyses of Duchenne muscular dystrophy and Becker muscular dystrophy muscles: changes contributing to preserve muscle function in Becker muscular dystrophy patients
by: Daniele Capitanio, et al.
Published: (2020-04-01)

Yesterday, today and tomorrow of Duchenne muscular dystrophy
by: Cheng ZHANG
Published: (2015-05-01)

Molecular Mechanisms that Underlie Duchenne Muscular Dystrophy
by: Babaria, Arati
Published: (2016)

CARDIAC COMPLICATIONS IN DUCHENNE MUSCULAR DYSTROPHY IN CHILDREN
by: Ioana Grigore, et al.
Published: (2015-12-01)

Tracking disease progression non‐invasively in Duchenne and Becker muscular dystrophies
by: Pietro Spitali, et al.
Published: (2018-08-01)

Dystrophin and the two related genetic diseases, Duchenne and Becker muscular dystrophies
by: Elisabeth Le Rumeur
Published: (2015-07-01)

Detection of the mutation may guide treatment of heart and muscle in Duchenne muscular dystrophy
by: Finsterer J, et al.
Published: (2016-03-01)

Molecular Diagnosis of Duchenne/Becker Muscular Dystrophy: Analysis of Exons Deletion and Carrier Detection
by: Mohammad Taghi Akbari, et al.
Published: (2010-01-01)

Research advance and application prospect of therapeutic strategies for Duchenne muscular dystrophy
by: Cheng ZHANG, et al.
Published: (2018-07-01)

Review the history of Duchenne muscular dystrophy and seize the cutting-edge research
by: Cheng ZHANG
Published: (2015-05-01)

Longitudinal Study of Three microRNAs in Duchenne Muscular Dystrophy and Becker Muscular Dystrophy
by: Selena Trifunov, et al.
Published: (2020-04-01)

PTX3 Predicts Myocardial Damage and Fibrosis in Duchenne Muscular Dystrophy
by: Andrea Farini, et al.
Published: (2020-05-01)

Language Delay in Duchenne’s Muscular Dystrophy
by: J Gordon Millichap
Published: (2007-06-01)

Brain Function in Duchenne Muscular Dystrophy
by: J. Gordon Millichap
Published: (2002-02-01)

Serum Creatinine Distinguishes Duchenne Muscular Dystrophy from Becker Muscular Dystrophy in Patients Aged ≤3 Years: A Retrospective Study
by: Liang Wang, et al.
Published: (2017-05-01)

Progressive muscular dystrophy: Duchenne type. Controversies of the kinesitherapy treatment
by: Ana Valéria de Araujo Leitão, et al.

Cardiomyopathy secondary to Duchenne muscular dystrophy in children
by: Iulia Rodoman, et al.
Published: (2021-06-01)

Motor clinical progression in a series of pediatric Duchenne and Becker muscular dystrophy cases
by: Zakiah Nur Istianah, et al.
Published: (2019-03-01)

Advance and cogitation of gene therapy for Duchenne muscular dystrophy
by: Cheng ZHANG, et al.
Published: (2019-05-01)